Melanie M. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Melanie M. Smith has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Harris
Health Sciences Integrated PhD Program, Northwestern University Feinberg School of Medicine Chicago Illinois USA
2 shared publications - Ava Coughlin
Northwestern University Feinberg School of Medicine, Chicago, IL, United States
2 shared publications - Cynthia Barnard
Departments of Medicine and Medical Social Sciences, Northwestern University Feinberg School of Medicine , Chicago, IL
2 shared publications - David Cella
Northwestern University, Evanston, USA
2 shared publications Elaine R. Cohen
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
2 shared publicationsGordon J. Wood
Department of Medicine and Department of Medical Education, Northwestern University Feinberg School of Medicine, Chicago, IL
2 shared publications
Latest Publications
- Open Access
- 21 November 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e70430
Association Between a Co-Designed Dashboard and Use of Costly Health Services in Patients With Chronic Kidney Disease and Advanced Cancer: Propensity Score–Adjusted Difference-in-Differences Study
Background: The US health care system faces escalating costs, increasing emphasis on patient autonomy, and a regulatory shift toward patient-centered care and patient-reported outcomes (PROs). Leveraging PROs to support shared decision-making has the potential to improve outcomes and reduce health care use for patients with advanced chronic conditions. Objective: This study aims to evaluate the impact of a PRO-based clinical dashboard on the use of costly health services among patients with advanced cancer and chronic kidney disease (CKD). Methods: We conducted a quasi-experimental, propensity score–weighted, difference-in-differences analysis using routinely collected data (June 2020 to January 2022) from a large US academic health system. Dashboard users were compared with contemporaneous nonexposed patients matched on clinical criteria. The primary outcomes were unplanned all-cause hospital admissions, potentially avoidable emergency department visits, excess days in acute care within 30 days of discharge, and 7-day readmissions. Cancer-specific secondary outcomes included acute encounters during outpatient chemotherapy, oncology triage use, advance directive completion, and hospice use. CKD-specific outcomes were CKD-related acute care use and disease progression. Results: In the advanced cancer cohort (dashboard users: n=284; dashboard nonusers: n=917), dashboard use was associated with significantly fewer chemotherapy-related emergency department or hospital encounters (ratio-in–odds ratios 0.35, 95% CI 0.16-0.75) and a nonsignificant 1.7–percentage point reduction in unplanned admissions (β=–0.017, 95% CI –0.107 to 0.072). Using Firth penalized logistic regression to reduce small sample bias, dashboard use was also associated with significantly higher odds of 7-day readmissions (ratio-in–odds ratios 8.58, 95% CI 2.28-32.32). Among readmissions in the dashboard user group, most (13/14, 93%) were scheduled by clinicians. Excess days in acute care increased by 4 percentage points (β=0.040, 95% CI –0.001 to 0.089). Advance directive completion declined significantly (β=–0.009, 95% CI –0.039 to 0.020). In the CKD cohort (dashboard users: n=365; dashboard nonusers: n=2137), no significant differences were observed for any primary or CKD-specific outcome. Conclusions: In routine oncology practice, a PRO dashboard was associated with fewer acute care encounters during chemotherapy but more planned early readmissions. The dashboard had no measurable effect on patients with CKD. These disease-specific mixed results highlight the need to tailor dashboards to the clinical context and embed them within workflows that can act on real-time PRO information.
- 21 November 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e70430
Open AccessAssociation Between a Co-Designed Dashboard and Use of Costly Health Services in Patients With Chronic Kidney Disease and Advanced Cancer: Propensity Score–Adjusted Difference-in-Differences Study
Background: The US health care system faces escalating costs, increasing emphasis on patient autonomy, and a regulatory shift toward patient-centered care and patient-reported outcomes (PROs). Leveraging PROs to support shared decision-making has the potential to improve outcomes and reduce health care use for patients with advanced chronic conditions. Objective: This study aims to evaluate the impact of a PRO-based clinical dashboard on the use of costly health services among patients with advanced cancer and chronic kidney disease (CKD). Methods: We conducted a quasi-experimental, propensity score–weighted, difference-in-differences analysis using routinely collected data (June 2020 to January 2022) from a large US academic health system. Dashboard users were compared with contemporaneous nonexposed patients matched on clinical criteria. The primary outcomes were unplanned all-cause hospital admissions, potentially avoidable emergency department visits, excess days in acute care within 30 days of discharge, and 7-day readmissions. Cancer-specific secondary outcomes included acute encounters during outpatient chemotherapy, oncology triage use, advance directive completion, and hospice use. CKD-specific outcomes were CKD-related acute care use and disease progression. Results: In the advanced cancer cohort (dashboard users: n=284; dashboard nonusers: n=917), dashboard use was associated with significantly fewer chemotherapy-related emergency department or hospital encounters (ratio-in–odds ratios 0.35, 95% CI 0.16-0.75) and a nonsignificant 1.7–percentage point reduction in unplanned admissions (β=–0.017, 95% CI –0.107 to 0.072). Using Firth penalized logistic regression to reduce small sample bias, dashboard use was also associated with significantly higher odds of 7-day readmissions (ratio-in–odds ratios 8.58, 95% CI 2.28-32.32). Among readmissions in the dashboard user group, most (13/14, 93%) were scheduled by clinicians. Excess days in acute care increased by 4 percentage points (β=0.040, 95% CI –0.001 to 0.089). Advance directive completion declined significantly (β=–0.009, 95% CI –0.039 to 0.020). In the CKD cohort (dashboard users: n=365; dashboard nonusers: n=2137), no significant differences were observed for any primary or CKD-specific outcome. Conclusions: In routine oncology practice, a PRO dashboard was associated with fewer acute care encounters during chemotherapy but more planned early readmissions. The dashboard had no measurable effect on patients with CKD. These disease-specific mixed results highlight the need to tailor dashboards to the clinical context and embed them within workflows that can act on real-time PRO information.
- Open Access
- 21 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Association Between a Co-Designed Dashboard and Use of Costly Health Services in Patients With Chronic Kidney Disease and Advanced Cancer: Propensity Score–Adjusted Difference-in-Differences Study (Preprint)
BACKGROUND The US health care system faces escalating costs, increasing emphasis on patient autonomy, and a regulatory shift toward patient-centered care and patient-reported outcomes (PROs). Leveraging PROs to support shared decision-making has the potential to improve outcomes and reduce health care use for patients with advanced chronic conditions. OBJECTIVE This study aims to evaluate the impact of a PRO-based clinical dashboard on the use of costly health services among patients with advanced cancer and chronic kidney disease (CKD). METHODS We conducted a quasi-experimental, propensity score–weighted, difference-in-differences analysis using routinely collected data (June 2020 to January 2022) from a large US academic health system. Dashboard users were compared with contemporaneous nonexposed patients matched on clinical criteria. The primary outcomes were unplanned all-cause hospital admissions, potentially avoidable emergency department visits, excess days in acute care within 30 days of discharge, and 7-day readmissions. Cancer-specific secondary outcomes included acute encounters during outpatient chemotherapy, oncology triage use, advance directive completion, and hospice use. CKD-specific outcomes were CKD-related acute care use and disease progression. RESULTS In the advanced cancer cohort (dashboard users: n=284; dashboard nonusers: n=917), dashboard use was associated with significantly fewer chemotherapy-related emergency department or hospital encounters (ratio-in–odds ratios 0.35, 95% CI 0.16-0.75) and a nonsignificant 1.7–percentage point reduction in unplanned admissions (β=–0.017, 95% CI –0.107 to 0.072). Using Firth penalized logistic regression to reduce small sample bias, dashboard use was also associated with significantly higher odds of 7-day readmissions (ratio-in–odds ratios 8.58, 95% CI 2.28-32.32). Among readmissions in the dashboard user group, most (13/14, 93%) were scheduled by clinicians. Excess days in acute care increased by 4 percentage points (β=0.040, 95% CI –0.001 to 0.089). Advance directive completion declined significantly (β=–0.009, 95% CI –0.039 to 0.020). In the CKD cohort (dashboard users: n=365; dashboard nonusers: n=2137), no significant differences were observed for any primary or CKD-specific outcome. CONCLUSIONS In routine oncology practice, a PRO dashboard was associated with fewer acute care encounters during chemotherapy but more planned early readmissions. The dashboard had no measurable effect on patients with CKD. These disease-specific mixed results highlight the need to tailor dashboards to the clinical context and embed them within workflows that can act on real-time PRO information.
- 21 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAssociation Between a Co-Designed Dashboard and Use of Costly Health Services in Patients With Chronic Kidney Disease and Advanced Cancer: Propensity Score–Adjusted Difference-in-Differences Study (Preprint)
BACKGROUND The US health care system faces escalating costs, increasing emphasis on patient autonomy, and a regulatory shift toward patient-centered care and patient-reported outcomes (PROs). Leveraging PROs to support shared decision-making has the potential to improve outcomes and reduce health care use for patients with advanced chronic conditions. OBJECTIVE This study aims to evaluate the impact of a PRO-based clinical dashboard on the use of costly health services among patients with advanced cancer and chronic kidney disease (CKD). METHODS We conducted a quasi-experimental, propensity score–weighted, difference-in-differences analysis using routinely collected data (June 2020 to January 2022) from a large US academic health system. Dashboard users were compared with contemporaneous nonexposed patients matched on clinical criteria. The primary outcomes were unplanned all-cause hospital admissions, potentially avoidable emergency department visits, excess days in acute care within 30 days of discharge, and 7-day readmissions. Cancer-specific secondary outcomes included acute encounters during outpatient chemotherapy, oncology triage use, advance directive completion, and hospice use. CKD-specific outcomes were CKD-related acute care use and disease progression. RESULTS In the advanced cancer cohort (dashboard users: n=284; dashboard nonusers: n=917), dashboard use was associated with significantly fewer chemotherapy-related emergency department or hospital encounters (ratio-in–odds ratios 0.35, 95% CI 0.16-0.75) and a nonsignificant 1.7–percentage point reduction in unplanned admissions (β=–0.017, 95% CI –0.107 to 0.072). Using Firth penalized logistic regression to reduce small sample bias, dashboard use was also associated with significantly higher odds of 7-day readmissions (ratio-in–odds ratios 8.58, 95% CI 2.28-32.32). Among readmissions in the dashboard user group, most (13/14, 93%) were scheduled by clinicians. Excess days in acute care increased by 4 percentage points (β=0.040, 95% CI –0.001 to 0.089). Advance directive completion declined significantly (β=–0.009, 95% CI –0.039 to 0.020). In the CKD cohort (dashboard users: n=365; dashboard nonusers: n=2137), no significant differences were observed for any primary or CKD-specific outcome. CONCLUSIONS In routine oncology practice, a PRO dashboard was associated with fewer acute care encounters during chemotherapy but more planned early readmissions. The dashboard had no measurable effect on patients with CKD. These disease-specific mixed results highlight the need to tailor dashboards to the clinical context and embed them within workflows that can act on real-time PRO information.
- 24 March 2024
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 68 (1) , e54-e61
Development of a Simulation-Based Mastery Learning Curriculum for Late Goals of Care Discussions
- 24 March 2024
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 68 (1) , e54-e61
Development of a Simulation-Based Mastery Learning Curriculum for Late Goals of Care Discussions
- 31 May 2022
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
- Vol. 40 (4) , 423-430
Clinical Experience Is Not a Proxy for Competence: Comparing Fellow and Medical Student Performance in a Breaking Bad News Simulation-Based Mastery Learning Curriculum
Background: It is unknown whether traditional medical education ensures competence among fellows in the key skill of breaking bad news (BBN). While simulation-based mastery learning (SBML) has been used to train fourth-year medical students (M4s) in BBN, it is unclear if it adds similar value for fellows. Objective: We examined the effect of traditional medical training on BBN skills by comparing baseline fellow and M4 skills and confidence and assessed the impact of a BBN SBML curriculum for fellows. Methods: Fellows training in six programs at Northwestern University from November 2018 to May 2019 were eligible for inclusion. Fellows completed a BBN SBML curriculum including a pretest, individualized feedback using a previously published assessment tool, and ongoing deliberate practice until all achieved a minimum passing standard (MPS). The primary outcomes were checklist and scaled item scores on the assessment tool. Fellow performance was compared to a historical M4 cohort. Results: Twenty-eight of 38 eligible fellows completed the curriculum and were included for analysis. Fellows reported significantly more experience and confidence in BBN compared to M4s, yet their pre-training performance was significantly worse on checklist (57.1% vs 65.0%, P = .02) and scaled items; only 4% reached the MPS. After training, fellow performance significantly improved on checklist (57.1% to 92.6%, SD = 5.2%, P < .001) and scaled items; all reached the MPS. Conclusions: Despite higher confidence and BBN clinical experience, fellows performed worse than untrained M4s, confirming that experience is not a proxy for skill. Programs must develop competency-based assessments to ensure entrustment of communication skills.
- 31 May 2022
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
- Vol. 40 (4) , 423-430
Clinical Experience Is Not a Proxy for Competence: Comparing Fellow and Medical Student Performance in a Breaking Bad News Simulation-Based Mastery Learning Curriculum
Background: It is unknown whether traditional medical education ensures competence among fellows in the key skill of breaking bad news (BBN). While simulation-based mastery learning (SBML) has been used to train fourth-year medical students (M4s) in BBN, it is unclear if it adds similar value for fellows. Objective: We examined the effect of traditional medical training on BBN skills by comparing baseline fellow and M4 skills and confidence and assessed the impact of a BBN SBML curriculum for fellows. Methods: Fellows training in six programs at Northwestern University from November 2018 to May 2019 were eligible for inclusion. Fellows completed a BBN SBML curriculum including a pretest, individualized feedback using a previously published assessment tool, and ongoing deliberate practice until all achieved a minimum passing standard (MPS). The primary outcomes were checklist and scaled item scores on the assessment tool. Fellow performance was compared to a historical M4 cohort. Results: Twenty-eight of 38 eligible fellows completed the curriculum and were included for analysis. Fellows reported significantly more experience and confidence in BBN compared to M4s, yet their pre-training performance was significantly worse on checklist (57.1% vs 65.0%, P = .02) and scaled items; only 4% reached the MPS. After training, fellow performance significantly improved on checklist (57.1% to 92.6%, SD = 5.2%, P < .001) and scaled items; all reached the MPS. Conclusions: Despite higher confidence and BBN clinical experience, fellows performed worse than untrained M4s, confirming that experience is not a proxy for skill. Programs must develop competency-based assessments to ensure entrustment of communication skills.